Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
5
×
startups
biology
boston
boston blog main
boston top stories
deals
health
life sciences
national blog main
new york blog main
new york top stories
tc
abbott laboratories
adel malek
artificial intelligence
aton partners
azacitidine
beta-thalassemia
cancer
carl heilman
cerevasc
chris garabedian
clinical trial
dacogen
dan levangie
decitabine
dna
endeavor
epigenetics
epizyme
farydak
fda
flagship pioneering
fulcrum therapeutics
fundings & exits
hydrocephalus
hydrocephalus association
implantable medical devices
insulated genomic domains
What
called
5
×
new
5
×
developing
medicines
based
biotech
company
drugs
focus
research
startup
absorb
addition
address
aims
algorithms
alltrna
announced
approach
batch
betting
biopharmaceutical
body
bottlenecks
brain
builds
celgene
cells
celularity
cerevasc
clinical
combinator’s
companies
cost
creating
curious
debuts
derived
development
device
Language
unset
Current search:
called
×
biotech
×
new
×
@techcrunch.com
2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@xconomy.com
3 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@techcrunch.com
6 years ago
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks
@techcrunch.com
6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas
